Legislative Session Starts; MMA to Focus on 5 Major Issues
February 19, 2026
State lawmakers returned to St. Paul on February 17 for the second half of the 2025-2026 biennium.
December 1, 2022
On November 30, the Minnesota Department of Health (MDH) announced that it will add irritable bowel syndrome (IBS) and obsessive-compulsive disorder (OCD) to the list of qualifying medical conditions for participation in Minnesota’s Medical Cannabis Program.
The new qualifying conditions will take effect August 1, 2023.
No petitions for new delivery methods were considered this year. Petitions for gastroparesis and opioid use disorder were not approved.
As in past years, MDH conducted a formal petitioning process to solicit public input on potential qualifying medical conditions and delivery methods for medicine. Minnesotans submitted petitions in June and July. Following that, the process moved into a public comment period and a review panel. MDH staff prepared reports that summarized research pertaining to the use of medical cannabis for each proposed condition.
Click here to see the entire list of qualifying conditions.
February 19, 2026
State lawmakers returned to St. Paul on February 17 for the second half of the 2025-2026 biennium.
February 19, 2026
On the second day of the legislative session, MMA leadership was already advocating for one of its top priorities - minimizing the harm of federal changes to Medical Assistance (MA).
February 19, 2026
Legislation to prohibit the use of artificial intelligence (AI) in prior authorization requirements was heard in the House Commerce Finance and Policy Committee on February 19.